Euroapi: Business Overview, Financials & Competitive Analysis
Euroapi is a European pharmaceutical company specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. Spun off from Sanofi in 2023, it serves as a critical supplier to pharmaceutical manufac...
Cyborg Score thesis
A well-positioned consolidation play in European pharmaceutical manufacturing with exposure to supply chain diversification...
Read the full analyst-debate transcript →Get the Latest Euroapi Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeEuroapi Overview
Pro stress-test →Euroapi is a European pharmaceutical company specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. Spun off from Sanofi in 2023, it serves as a critical supplier to pharmaceutical manufacturers across Europe and globally.
Strategic Profile
Pro stress-test →The company positions itself as an independent API and pharmaceutical manufacturer, leveraging operational expertise and capacity across multiple European facilities. Euroapi targets customers seeking diversified supply chains and alternative sources beyond major integrated pharmaceutical players.
Competitive Landscape
Pro stress-test →Euroapi competes with integrated pharmaceutical companies (Sanofi, GSK), specialized API manufacturers (Albemarle, Cambrex), and emerging competitors in India and China. The company differentiates through European location, regulatory compliance, and established supply relationships.
Industry Context
Euroapi operates in Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients.
Key facts
Founded: 2023 · Headquarters: Lisses, France · Employees: 6,500 · Revenue: $2.2B